Found: 16
Select item for more details and to access through your institution.
Enhanced Weight Loss Following Coadministration of Pramlintide With Sibutramine or Phentermine in a Multicenter Trial.
- Published in:
- Obesity (19307381), 2010, v. 18, n. 9, p. 1739, doi. 10.1038/oby.2009.478
- By:
- Publication type:
- Article
Effect of Pramlintide on Weight in Overweight and Obese Insulin-Treated Type 2 Diabetes Patients<sup>**</sup>.
- Published in:
- Obesity (19307381), 2004, v. 12, n. 4, p. 661, doi. 10.1038/oby.2004.76
- By:
- Publication type:
- Article
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease.
- Published in:
- Drugs, 2024, v. 84, n. 7, p. 811, doi. 10.1007/s40265-024-02067-8
- By:
- Publication type:
- Article
The Relationship of Pronuclear Stage Morphology and Chromosome Status at Cleavage Stage.
- Published in:
- Journal of Assisted Reproduction & Genetics, 2003, v. 20, n. 10, p. 413, doi. 10.1023/A:1026232625659
- By:
- Publication type:
- Article
Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QT<sub>c</sub> interval in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 4, p. 979, doi. 10.1111/j.1365-2125.2012.04416.x
- By:
- Publication type:
- Article
CLINICAL EFFECTS OF TRAMIPROSATE IN APOE4 HOMOZYGOTES WITH MILD TO MODERATE ALZHEIMER'S DISEASE (AD) ARE SUSTAINED OVER 130 WEEKS: RESULTS OF A PHASE 3 EXTENSION STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P256, doi. 10.1016/j.jalz.2017.06.119
- By:
- Publication type:
- Article
Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. 5, p. 411, doi. 10.1002/dmrr.499
- By:
- Publication type:
- Article
Properties of pramlintide and insulin upon mixing.
- Published in:
- American Journal of Health-System Pharmacy, 2005, v. 62, n. 8, p. 816, doi. 10.1093/ajhp/62.8.816
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.
- Published in:
- American Journal of Health-System Pharmacy, 2005, v. 62, n. 2, p. 173., doi. 10.1093/ajhp/62.2.173
- By:
- Publication type:
- Article
DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks.
- Published in:
- 2010
- By:
- Publication type:
- journal article
DURATION-1. Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks.
- Published in:
- Diabetes Care, 2010, v. 33, n. 6, p. 1255, doi. 10.2337/dc09-1914
- By:
- Publication type:
- Article
Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2002, v. 25, n. 4, p. 724, doi. 10.2337/diacare.25.4.724
- By:
- Publication type:
- Article
Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2011, v. 10, n. 1, p. 22, doi. 10.1186/1475-2840-10-22
- By:
- Publication type:
- Article
Consistency of continual reassessment method under model misspecification.
- Published in:
- Biometrika, 1996, v. 83, n. 2, p. 395, doi. 10.1093/biomet/83.2.395
- By:
- Publication type:
- Article